These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 32457420)
41. A historical look at the first reported cases of Lassa fever: IgG antibodies 40 years after acute infection. Bond N; Schieffelin JS; Moses LM; Bennett AJ; Bausch DG Am J Trop Med Hyg; 2013 Feb; 88(2):241-4. PubMed ID: 23390223 [TBL] [Abstract][Full Text] [Related]
42. An Outbreak of Ebola Virus Disease in the Lassa Fever Zone. Goba A; Khan SH; Fonnie M; Fullah M; Moigboi A; Kovoma A; Sinnah V; Yoko N; Rogers H; Safai S; Momoh M; Koroma V; Kamara FK; Konowu E; Yillah M; French I; Mustapha I; Kanneh F; Foday M; McCarthy H; Kallon T; Kallon M; Naiebu J; Sellu J; Jalloh AA; Gbakie M; Kanneh L; Massaly JL; Kargbo D; Kargbo B; Vandi M; Gbetuwa M; Gevao SM; Sandi JD; Jalloh SC; Grant DS; Blyden SO; Crozier I; Schieffelin JS; McLellan SL; Jacob ST; Boisen ML; Hartnett JN; Cross RW; Branco LM; Andersen KG; Yozwiak NL; Gire SK; Tariyal R; Park DJ; Haislip AM; Bishop CM; Melnik LI; Gallaher WR; Wimley WC; He J; Shaffer JG; Sullivan BM; Grillo S; Oman S; Garry CE; Edwards DR; McCormick SJ; Elliott DH; Rouelle JA; Kannadka CB; Reyna AA; Bradley BT; Yu H; Yenni RE; Hastie KM; Geisbert JB; Kulakosky PC; Wilson RB; Oldstone MB; Pitts KR; Henderson LA; Robinson JE; Geisbert TW; Saphire EO; Happi CT; Asogun DA; Sabeti PC; Garry RF; J Infect Dis; 2016 Oct; 214(suppl 3):S110-S121. PubMed ID: 27402779 [TBL] [Abstract][Full Text] [Related]
43. Lesson learned from the investigation and response of Lassa fever outbreak, Margibi County, Liberia, 2018: case report. Woyessa AB; Maximore L; Keller D; Dogba J; Pajibo M; Johnson K; Saydee E; Monday J; Tuopileyi R; Mahmoud N BMC Infect Dis; 2019 Jul; 19(1):610. PubMed ID: 31296177 [TBL] [Abstract][Full Text] [Related]
44. Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs. Maruyama J; Mateer EJ; Manning JT; Sattler R; Seregin AV; Bukreyeva N; Jones FR; Balint JP; Gabitzsch ES; Huang C; Paessler S Vaccine; 2019 Oct; 37(45):6824-6831. PubMed ID: 31561999 [TBL] [Abstract][Full Text] [Related]
45. Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever. Saijo M; Georges-Courbot MC; Marianneau P; Romanowski V; Fukushi S; Mizutani T; Georges AJ; Kurata T; Kurane I; Morikawa S Clin Vaccine Immunol; 2007 Sep; 14(9):1182-9. PubMed ID: 17634509 [TBL] [Abstract][Full Text] [Related]
46. Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa. Emmerich P; Thome-Bolduan C; Drosten C; Gunther S; Ban E; Sawinsky I; Schmitz H J Clin Virol; 2006 Dec; 37(4):277-81. PubMed ID: 16996789 [TBL] [Abstract][Full Text] [Related]
47. Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak. Boisen ML; Schieffelin JS; Goba A; Oottamasathien D; Jones AB; Shaffer JG; Hastie KM; Hartnett JN; Momoh M; Fullah M; Gabiki M; Safa S; Zandonatti M; Fusco M; Bornholdt Z; Abelson D; Gire SK; Andersen KG; Tariyal R; Stremlau M; Cross RW; Geisbert JB; Pitts KR; Geisbert TW; Kulakoski P; Wilson RB; Henderson L; Sabeti PC; Grant DS; Garry RF; Saphire EO; Branco LM; Khan SH; Viral Immunol; 2015 Feb; 28(1):19-31. PubMed ID: 25531344 [TBL] [Abstract][Full Text] [Related]
51. Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study. Grant DS; Engel EJ; Roberts Yerkes N; Kanneh L; Koninga J; Gbakie MA; Alhasan F; Kanneh FB; Kanneh IM; Kamara FK; Momoh M; Yillah MS; Foday M; Okoli A; Zeoli A; Weldon C; Bishop CM; Zheng C; Hartnett J; Chao K; Shore K; Melnik LI; Mucci M; Bond NG; Doyle P; Yenni R; Podgorski R; Ficenec SC; Moses L; Shaffer JG; Garry RF; Schieffelin JS PLoS Negl Trop Dis; 2023 Feb; 17(2):e0010938. PubMed ID: 36758101 [TBL] [Abstract][Full Text] [Related]
52. Sequence variability and geographic distribution of Lassa virus, Sierra Leone. Leski TA; Stockelman MG; Moses LM; Park M; Stenger DA; Ansumana R; Bausch DG; Lin B Emerg Infect Dis; 2015 Apr; 21(4):609-18. PubMed ID: 25811712 [TBL] [Abstract][Full Text] [Related]
53. Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria. Happi AN; Olumade TJ; Ogunsanya OA; Sijuwola AE; Ogunleye SC; Oguzie JU; Nwofoke C; Ugwu CA; Okoro SJ; Otuh PI; Ngele LN; Ojo OO; Adelabu A; Adeleye RF; Oyejide NE; Njaka CS; Heeney JL; Happi CT Microbiol Spectr; 2022 Aug; 10(4):e0036622. PubMed ID: 35913205 [TBL] [Abstract][Full Text] [Related]
54. Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational study. Strampe J; Asogun DA; Speranza E; Pahlmann M; Soucy A; Bockholt S; Pallasch E; Becker-Ziaja B; Duraffour S; Bhadelia N; Ighodalo Y; Oyakhilome J; Omomoh EO; Olokor T; Adomeh DI; Ikponwonsa O; Aire C; Tobin E; Akpede N; Okokhere PO; Okogbenin SA; Akpede GO; Muñoz-Fontela C; Ogbaini-Emovon E; Günther S; Connor JH; Oestereich L Lancet Infect Dis; 2021 Jun; 21(6):876-886. PubMed ID: 33484646 [TBL] [Abstract][Full Text] [Related]